Glenmark launches COVID-19 drug after DCGI nod

The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fHWiX7
via IFTTT

0 comments:

Post a Comment